Fatty acid synthase (FaS), an essential enzyme for de novo lipogenesis, has been implicated in a number of disease states, including obesity, dyslipidemia, and cancer. to identify small-molecule inhibitors of FaS, the authors developed a beadbased scintillation proximity assay (SPa) to detect the fatty acid products of FaS enzymatic activity. this homogeneous SPa assay discriminates between a radiolabeled hydrophilic substrate of FaS (acetyl-coenzyme a) and the labeled lipophilic products of FaS (fatty acids), generating signal only when labeled fatty acids are present. the assay requires a single addition of unmodified polystyrene imaging SPa beads and can be miniaturized to 384-or 1536-well density with appropriate assay statistics for high-throughput screening. high-potency FaS inhibitors were used to compare the sensitivity of the SPa bead assay with previously described assays that measure FaS reaction intermediates (coa-Sh and nadP + ). the advantages and disadvantages of these different FaS assays in small-molecule inhibitor discovery are discussed. (Journal of Biomolecular Screening 2009:636-642) 
INTRODUCTION
F atty acid SynthaSe (FaS) haS long attracted Study by biochemists due to its central role in de novo lipogenesis. FaS is a complex molecular machine capable of polymerizing hydrophilic 2-carbon precursors into long hydrophobic fatty acids. this polymerization is accomplished by 6 different enzymatic activities contained in a single FaS protein in mammals, 1 2 proteins in budding yeast, 2 and 6 different proteins in plants and eubacteria. 3 these differences in FaS enzymatic architecture have been successfully exploited in the discovery of antimicrobial agents. 4 interest in the pharmacological modulation FaS activity in humans has been, until recently, driven primarily by the role of FaS in obesity and dyslipidemias. 5 lately, development of FaS inhibitors has expanded into oncology as data accumulate, implicating a role for FaS in the development and/or maintenance of neoplasms. 6 Previous biochemical research into FaS has generated a number of assays for FaS enzymatic activity, and some of these assays have been used in high-throughput screening (htS). as illustrated in Figure 1 , FaS assays can be classified according to those that measure the production or consumption of FaS reaction intermediates and those that measure the final products of the FaS enzymatic reaction: free fatty acids. in choosing an assay for the measurement of fatty acids, the consideration of previously published htS-compatible assays for FaS production of fatty acids revealed several limitations. one published 2-phase partition assay relies on a viscous liquid scintillation fluid that can be difficult to rapidly and accurately dispense in low microliter volumes. 7 in addition, the light emission from the scintillation fluid is blue-shifted, a less favorable emission profile for compound screening compared to red light emission. another assay using the scintillation format for fatty acids requires the phospholipid coating of a scintillating microplate to capture labeled fatty acids. 8 however, such scintillating microplates are not commercially available in higher density formats such as 1536-or 3456-well plates. to overcome these limitations, we developed a scintillation proximity assay (SPa) bead for FaS enzymatic activity. the use of imaging SPa beads overcomes limitations of previously described FaS assays in that the bead format is scalable to high density and readily amenable to automation, and light emission is redshifted to avoid compound interference. Furthermore, no separate lipid coating of the beads is required. commercially available imaging SPa beads can be used in the detection of FaS-generated fatty acids with no additional modification, resulting in the potential for lower cost as well as increased efficiency and reduced variation due to simplified bead handling. the SPa bead assay compares favorably with previously developed FaS assays, displaying appropriate assay statistics and comparable inhibitor potency values.
RESULTS AND DISCUSSION
Because SPas are highly sensitive and htS compatible, this technology was used to develop a high-sensitivity assay to measure activity of the enzyme FaS. SPa beads or microplates can be supplied with different surface coatings (nickel chelate, wheat germ agglutinin, streptavidin, etc.) to facilitate specific binding of radiolabeled molecules to the scintillating bead or microplate surface. Previously published FaS SPa microplate assays employed biotinylated phospholipids and streptavidincoated microplates to create a phospholipid surface to facilitate binding of fatty acids. 8, 9 development of an SPa bead assay began with the assumption that a lipid coating was necessary to facilitate binding of fatty acids to the SPa bead surface. however, assay development also sought to avoid potential nonspecific fatty acid or compound binding to the streptavidin used in previous methods. to create an alternate lipid coating on imaging SPa beads that did not employ proteins, we further coated polystyrene (PS) nickel-chelate imaging SPa beads (termed hiS-tag SPa imaging beads) with the fatty acid 1,2dioleoyl-sn-glycero-3-[(n-(5-amino-1-carboxypentyl)iminodiacetic acid)succinyl] (dgS-nta), exploiting its transition metal-chelating headgroup to bind the fatty acid to the beads. to test the performance of this lipid coating in a SPa assay, we incubated lipid-coated SPa beads separately with either [3h]acetyl-coa (hydrophilic FaS substrate) or [3h]-palmitate (hydrophobic FaS product). a luminescent signal was detected when lipid-coated beads were incubated with a nanomolar concentration of [3h]-palmitate but not when incubated with nanomolar [3h]-acetyl-coa ( Fig. 2A , "lipid-coated + [3h]-palmitate" vs. "lipid-coated + [3h]-acetyl-coa"). only incubation of lipid-coated beads with micromolar concentrations of [3h]acetyl-coa was able to generate a small signal, but this signal from [3h]-acetyl-coa was at least 20-fold lower than the signal from incubation with [3h]-palmitate ( Fig. 2A and "Blank" Imaging SPA beads
FIG. 2.
Signal from acetyl-coa and palmitate using different imaging scintillation proximity assay (SPa) beads with and without lipid coatings. indicated concentrations of either [3h]-acetyl-coa or [3h]palmitate were added to (A) his-tag imaging SPa beads or (B) "blank" uncoated imaging SPa beads coated with lipids as indicated. Bars represent the mean signal obtained for each condition with n ≥ 3 for each condition and replicate of experiment n ≥ 3. Measurements consistently showed a coefficient of variance ≤5% for each condition shown. no statistically significant difference was consistently observed when comparing signal from beads with and without lipid coating. SPa assay, measure the accumulation or depletion of reaction intermediates and not the fatty acid product of FaS enzymatic activity. the first assay, a nicotinamide adenine dinucleotide phosphate (nadPh) assay, measures the depletion of nadPh required for the FaS enzymatic reaction via loss of nadPh fluorescence or absorbance upon its conversion to nadP+ ( Fig. 1) . the nadPh assay is especially suited for kinetic analysis as no separate addition is needed for detection. a second assay employs a maleimide derivative of the dye coumarin (7-diethylamino-3-(4-maleimidophenyl)-4-methylcoumarin [cPM]), which is nonfluorescent until it reacts with a free thiol group. in the FaS enzymatic reaction, cPM can be used to monitor the production of free coa generated from the acetylcoa and malonyl-coa substrates. We were especially interested in comparing the kinetics of the cPM and nadPh assays to the SPa assay because work with the first 2 assays had shown an initial rapid reaction rate followed by a slower rate of product formation. indeed, as monitored in all 3 assays, the FaS reaction does not proceed at 1 rate. an initial rapid rate is observed until approximately 15 min, but the reaction then slows considerably ( Fig. 3A-C) . Such a decrease in reaction rate can be due to product inhibition of the enzyme, and this has been reported previously for the FaS enzyme: coa itself can serve as an inhibitor of FaS. 10, 11 to verify that this same coa product inhibition was occurring in our reaction conditions, we monitored FaS reactions containing different concentrations of each of the products of the FaS reaction: coa, nadP+, and palmitate. only coa inhibited the FaS reaction in a concentration-dependent manner (data not shown), confirming that coa product inhibition was occurring under our assay conditions. Because of this phenomenon, reaction times in each of the assays were kept under 15 min during compound testing.
as the goal of each of these assays was the identification of small-molecule inhibitors of FaS, we tested several FaS inhibitors in the SPa assay and compared the results to the cPM and nadPh assays. We used a series of inhibitors developed in-house and described previously as we understood these to be some of the most potent FaS enzyme inhibitors described to date. 12 dose-response curves were generated using the FaS SPa assay, and potencies were calculated from the inflection point of a 4-parameter fit ( Fig. 4 and Table 1 ). Potencies determined using the SPa assay were comparable to those determined using the cPM and nadPh assays ( Table  1 ). these data indicated that the SPa bead assay described here measuring the final palmitate product of FaS was capable of determining FaS inhibitor potency with results comparable to those of assays measuring intermediate products of FaS enzymatic activity (coa-Sh and nadP + ). the equivalency of all 3 assays in determining compound potency prompts the question of which of the available assays (naPdh, cPM, or SPa) for FaS is best suited for the discovery of small inhibitors of FaS. as a presumptive negative control. however, when these lipidfree SPa beads were incubated with [3h]-palmitate, the signal generated was statistically identical to that of the lipid-coated beads ( Fig. 2A , "no lipid + [3h]-palmitate"), and the same low signal was seen when lipid-free beads were incubated with [3h]-acetyl-coa ( Fig. 2A , "no lipid + [3h]-acetyl-coa"). these data raised the possibility that the observed [3h]-palmitate preference was specific to his-tag imaging beads or that the his-tag lipid coating protocol was not effective (i.e., did not create a more hydrophobic surface than the unmodified bead surface). to test these possibilities, we coated streptavidin imaging SPa beads with the biotinylated phospholipid nbiotinyl-dipalmitoylphosphatidylethanolamine (B-dPPe) using a method described previously. 9 despite the different imaging SPa beads and lipid-coating protocol, identical results were obtained: streptavidin imaging SPa beads were able to discriminate between [3h]-palmitate and [3h]-acetyl-coa, and the presence of a lipid coating made no statistically significant difference in the window between [3h]-palmitate and [3h]-acetyl-coa (data not shown).
Because both nickel-chelate and streptavidin polystyrene imaging SPa beads behaved similarly, we reasoned that the hydrophobic [3h]-palmitate was binding to the polystyrene surface of the beads, whereas the hydrophilic [3h]-acetyl-coa bound with significantly lower affinity. to test this hypothesis, we procured polystyrene imaging SPa beads with no coating at all (ge healthcare life Sciences, Piscataway, nJ, special request). these "blank" imaging SPa beads behaved exactly as the his-tag and streptavidin imaging SPa beads. in fact, the signal window with "blank" beads appeared to be even higher than the previous 2 types tested (Fig. 2B) . together, these results suggested that it was possible to construct a very simple and robust assay for the [3h]-palmitate product of the FaS enzymatic reaction as no special lipid coating of imaging SPa beads was apparently necessary.
to test the ability of imaging SPa beads to measure the enzymatic activity of FaS, we used a mixture of [3h]-acetylcoa, unlabeled acetyl-coa, and malonyl-coa as the substrates for FaS in an enzymatic reaction. these reactions were allowed to proceed until specific times when separate reactions were stopped by the addition of a stop/read buffer containing his-tag imaging SPa beads. readings at each time point indicated a time-dependent generation of signal as [3h]-fatty acids were produced in the FaS enzymatic reaction (Fig. 3A) . assay statistics (Z′ and signal to background [S/B]) were determined, and Z′ scores ≥0.5 were obtained for each time point past and including 5 min. acceptable statistics were obtained in both 384-well (Z′ = 0.6 for 5 min and 0.7 for 15 min) and 1536-well (Z′ = 0.5 for 5 min and 0.7 for 15 min) formats with coefficient of variation (cV) percentages <10% in each format.
We considered it valuable to compare the FaS SPa bead assay described here to existing assays for FaS activity that, unlike the the homogeneous nadPh absorbance assay allows realtime monitoring of the same assay well and can be readily used to quantitate nadPh consumption. thus, it is a standard assay for the kinetic characterization of FaS enzymatic activity. however, the nadPh absorbance assay is probably the least amenable for compound screening due to the large number of compounds that absorb light in the near-uV 340-nm range. the nadPh fluorescence assay also suffers from the issue of absorbance at 340 nm but adds additional opportunities for compound interference at its blue-shifted fluorescence emission at 450 nm. nadPh assays for FaS are also loss-ofsignal assays, and this, combined with product inhibition of the FaS reaction, results in an inherently low limit to the maximum attainable S/B ratio and Z′ (we routinely observed S/B < 2 and Z′ < 0.5, data not shown).
htS-compatible assays for the FaS reaction intermediate coa-Sh require the reaction of coa-Sh with a sulfhydrylreactive probe to generate luminescence (as with reagents such as thio-glo) or fluorescence (as with the maleimidyl coumarin dye, cPM). unlike the nadPh assays, these assays for coa-Sh are gain-of-signal assays and can perform with assay statistics suitable for htS. 13 however, an important consideration for htS is that the thiol-reactive probes used in the assay of coa-Sh are not specific for coa-Sh, and signal artifacts can be generated by reaction with a variety of reactive thiols. 14 thus, use of an assay employing a thiol-reactive probe may require counterscreening of initial hits to identify sulfhydrylgenerated false positives. even though the structure of the intended molecule being screened may not contain a free sulfhydryl, false positives can be readily generated from sulfhydryl-reactive contaminants of compound solutions.
an assay that measures the final fatty acid products of FaS catalysis is able to measure inhibition of any of the 6 FaS enzymatic activities. an assay for fatty acid production also presents an opportunity to circumvent the issues of reactivity and interference in assays that measure intermediates of FaS enzyme activity. however, as described in the introduction, previously published assays of FaS fatty acid production are limited in scale, speed, and simplicity. the FaS SPa bead assay described here overcomes these limitations. the 1-step addition of unmodified commercially available imaging SPa beads allows for rapid processing and full ultra-htS-scale miniaturization, making the assay an attractive option for the identification of FaS inhibitors. thus, the advantage of measuring the final FaS reaction product is combined with assay simplicity and performance.
MATERIALS AND METHODS

Reagents and materials
FaS enzyme was purified from human SK-Br3 cells using a method described previously. dgS-nta was obtained from avanti Polar lipids (alabaster, al). all other chemicals were obtained from Sigma (St. louis, Mo), at reagent grade or higher. in FaS enzymatic reactions, buffers were prepared fresh from frozen (-20 °c) stock solutions except for dithiothreitol (dtt) and naPdh solutions, which were prepared fresh for each assay run. Serial dilutions of [3h]-palmitate were performed in absolute ethanol. Serial dilutions of [3h]acetyl-coa were performed in 75 mM potassium phosphate buffer, ph 6.8. then, 1 µl of these dilutions was added to 9 µl of 75 mM potassium phosphate buffer (ph 6.8) containing 50 ng/µl of imaging SPa beads in a 384-well ProxiPlate hS microplate. Signal from SPa beads was measured using a luminescence protocol on a Viewlux microplate imager (Perkinelmer, Waltham, Ma). For fluorescence intensity assays, 384-well black polystyrene microplates with nonbinding surface were used (corning #3676). For absorbance assays, 384-well clear polystyrene uV-transparent microplates were used (corning #3675). For SPa assay, 384-well ProxiPlate hS or 1536-well white optiPlate was used (Perkinelmer).
NADPH absorbance assay
FaS activity was determined by adding serial dilutions of purified FaS enzyme in the nadPh activity buffer: 100 mM potassium phosphate (ph 6.5), 1 mM dtt, 25 µM acetyl-coa, and 150 µM nadPh. FaS reactions were initiated by the addition of substrate: 500 µM malonyl-coa in nadPh activity buffer. in 100-µl reactions, 10 µl of substrate was added to a 90-µl activity buffer to yield 50 µM malonyl-coa in the reaction. nadPh conversion to nadP was monitored by loss of absorbance at 340 nm using the kinetic mode of the SpectraMax M2 plate reader (Molecular devices, Sunnyvale, ca). Specific activity of the FaS enzyme (FaS units/mg protein) was defined as µMoles nadPh consumed⋅min -1 ⋅mg -1 . an extinction coefficient of 6220 M -1 cm -1 was used in the specific activity calculation. Mean potency values were obtained from the mean inflection point of a 4-parameter logistic fit using percent inhibition values. Means were derived from n ≥ 3 independent titrations. SPa, scintillation proximity assay; nadPh, nicotinamide adenine dinucleotide phosphate; cPM, 7-diethylamino-3-(4-maleimidophenyl)-4-methylcoumarin.
NADPH fluorescence intensity assay
FaS enzyme was diluted in FaS enzyme buffer to 2 µunits/ µl final concentration unless otherwise noted. FaS enzyme buffer was composed of 75 mM potassium phosphate (ph 6.8), 50 µM edta, 1 mM sodium ascorbate, 25 µM acetyl-coa, and 150 µM nadPh. reactions were initiated by the addition of malonyl-coa in FaS enzyme buffer to a final concentration of 210 µM. nadPh fluorescence was measured using the enVision plate reader (Perkinelmer) with an excitation wavelength of 340 nm, an emission wavelength of 450 nm, and a dichroic mirror at 400 nm. endpoint assays were incubated at room temperature for 10 min before reading.
CPM fluorescence intensity assay
cPM assay was performed exactly as the nadPh fluorescence intensity assay except reaction was stopped at 10 min by the addition of cPM stop buffer: 60% 75 mM potassium phosphate (ph 6.8), 40% ethanol, and 132 µM cPM (cPM stock solutions at 66 mM were made in anhydrous dMSo and stored at -20 °c). cPM fluorescence was measured using a Viewlux microplate imager (Perkinelmer) using an excitation wavelength of 380 nm, an emission wavelength of 450 nm, and a dichroic mirror at 400 nm. assays for compound potency were assembled by addition of 9 µl FaS enzyme in FaS enzyme buffer to the empty microplate followed by 0.5 µl compound in dMSo (addition and mixing by Matrix PlateMate Plus, hudson, nh). Plates were incubated for 20 min at room temperature before addition of 1 µl malonyl-coa substrate in FaS enzyme buffer. reaction was allowed to proceed for exactly 10 min at room temperature before the addition of 2.2 µl cPM stop buffer. Plates were incubated for 15 min at room temperature before reading.
FAS SPA Assay
FaS enzyme was used at a final reaction concentration of 2 µunits/µl in a buffer of 75 mM potassium phosphate (ph 6.8), 1 mM dtt, 150 µM nadPh, 3.125 µM (1.5 nci/µl) [3h]-acetyl-coa (from 0.95 µci/µl stock, ge healthcare life Sciences), and 21.875 µM unlabeled acetyl-coa. then, 8 µl of this FaS enzyme buffer was added per well of a lowvolume 384-well plate (ProxiPlate hS) or 1536-well plate (optiPlate). next, 1 µl of compound in dMSo or dMSo alone was added to each well and allowed to incubate for 20 min at room temperature. reactions were initiated by the addition of 1 µl FaS substrate (210 µM malonyl-coa in 75 mM potassium phosphate [ph 6.8], 1 mM dtt, 150 µM nadPh) and allowed to proceed for 15 min at room temperature. then, 3 µl of a stop/read buffer was then added to each well. this buffer contained 250 ng/µl of SPa beads in 1 M tris, ph 9. Plates were then read using a Viewlux microplate imager (Perkinelmer) using a luminescence protocol and clear filter. in time course experiments, stop buffer was added separately from SPa beads so that incubation time with SPa beads was equal among reactions.
Lipid coating of SPA beads
hiS-tag SPa imaging beads (ge healthcare life Sciences) were coated with the nickel-chelating lipid dgS-nta. then, 1-mg/ml stock solutions of dgS-nta were prepared in absolute ethanol by heating to 50 °c in a sonicating water bath (Branson) for 1 h. equal volume of hiS-tag SPa imaging beads at 1 mg/ml (undiluted from purchased solution) was added to dgS-nta stock solution and incubated for 1 h in a sonicating water bath. Beads were then washed 2 times with a solution of 50% ethanol and 50% 75 mM potassium phosphate (ph 6.8), followed by 3 washes with 75 mM potassium phosphate (ph 6.8) and 0.01% tween-20. Beads were stored at 4 °c as a 1-µg/µl solution in 75 mM potassium phosphate (ph 6.8) and 0.01% tween-20. Streptavidin SPa imaging beads were coated with B-dPPe using an identical protocol except ethanol was kept at 10% concentration with stock concentration of B-dPPe at 5 mg/ml.
